IMUNON INC. - COMMON
1.0100
07-October-24 15:59:45
15 minutes delayed
Stocks
-0.0700
-6.48%
Today's range
1.0100 - 1.0700
ISIN
N/A
Source
NASDAQ
-
21 Mar 2024 17:00:00 By Nasdaq GlobeNewswire
-
IMUNON Files IND Application to Begin Human Testing of IMNN-101
13 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
IMUNON Announces Leadership Change
12 Mar 2024 17:00:00 By Nasdaq GlobeNewswire
-
29 Feb 2024 08:30:00 By Nasdaq GlobeNewswire
-
27 Feb 2024 08:30:00 By Nasdaq GlobeNewswire
-
IMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccine
22 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
11 Dec 2023 08:30:00 By Nasdaq GlobeNewswire
-
IMUNON’s VP of R&D to Present at the Vaccines Summit-2023
14 Nov 2023 09:00:00 By Nasdaq GlobeNewswire
-
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
14 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
07 Nov 2023 08:30:00 By Nasdaq GlobeNewswire
-
IMUNON’s Chief Science Officer to Present at the 3rd International Vaccines Congress
23 Oct 2023 08:30:00 By Nasdaq GlobeNewswire
-
19 Oct 2023 08:30:00 By Nasdaq GlobeNewswire
-
18 Oct 2023 08:30:00 By Nasdaq GlobeNewswire
-
IMUNON Appoints Dr. Patrick Ott to its Scientific Advisory Board
06 Oct 2023 08:30:00 By Nasdaq GlobeNewswire